Literature DB >> 34524519

Implementation and outcomes of enhanced recovery protocols in pediatric surgery: a systematic review and meta-analysis.

Arun Kumar Loganathan1, Anita Shirley Joselyn2, Malavika Babu3, Susan Jehangir4.   

Abstract

BACKGROUND: This systematic review examines the feasibility and safety of implementing Enhanced recovery after Surgery (ERAS) protocols in children. STUDY
DESIGN: A systematic search of Medline, PubMed, and the Cochrane library for papers describing ERAS implementation in children between January 2000 and January 2021. The systematic review was performed according to the PRISMA statement. The meta-analysis was done using R Software (Ver 4.0.2). p value of < 0.05 was considered statistically significant.
RESULTS: Sixteen studies, describing a total of 1723 patients, were included in the meta-analysis. An average of 15 (range 11-16) relevant components were implemented with an overall compliance close to 84%. The time to initiate feeds and reach full enteral nutrition was reduced in ERAS group with mean difference (MD) of - 21.20 h (95% CI - 22.80, - 19.59, p < 0.01), and - 2.20 days (95% CI - 2.72, - 1.71, p < 0.01), respectively. The use of opioids for postoperative analgesia was reduced with MD of -0.86 morphine equivalents mg/kg (95% CI - 1.40, - 0.32, p < 0.01). The length of hospital stay showed a significant reduction with MD of -2.54 days (95% CI - 2.94, - 2.13, p < 0.01). There was no difference in the complication and readmission rates between the groups.
CONCLUSION: ERP implementation in pediatric perioperative care is a viable option in a variety of surgical settings. There is clear evidence of a decrease in hospital stay duration with no increase in complication or readmission rates. The length of hospital stay reduced in inverse proportion to the number of ERAS elements implemented. Parental satisfaction is increased by initiating enteral feeding early, minimizing catheter and drain use, and reducing opioid use.
© 2021. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  Children; ERAS; Enhanced recovery; Paediatric surgery

Mesh:

Substances:

Year:  2021        PMID: 34524519     DOI: 10.1007/s00383-021-05008-8

Source DB:  PubMed          Journal:  Pediatr Surg Int        ISSN: 0179-0358            Impact factor:   1.827


  28 in total

Review 1.  Enhanced recovery after surgery in paediatrics: a review of the literature.

Authors:  K Roberts; M Brindle; D McLuckie
Journal:  BJA Educ       Date:  2020-05-06

2.  Enhanced recovery after surgery and anesthetic outcomes in pediatric reconstructive urologic surgery.

Authors:  Daniel S Han; Megan A Brockel; Peter J Boxley; M İ Dönmez; Amanda F Saltzman; Duncan T Wilcox; Kyle O Rove
Journal:  Pediatr Surg Int       Date:  2020-11-07       Impact factor: 1.827

Review 3.  Enhancing recovery in pediatric surgery: a review of the literature.

Authors:  Julia K Shinnick; Heather L Short; Kurt F Heiss; Matthew T Santore; Martin L Blakely; Mehul V Raval
Journal:  J Surg Res       Date:  2016-01-12       Impact factor: 2.192

Review 4.  Embracing change: the era for pediatric ERAS is here.

Authors:  Mary E Brindle; Kurt Heiss; Michael J Scott; C Anthony Herndon; Olle Ljungqvist; Martin A Koyle
Journal:  Pediatr Surg Int       Date:  2019-04-25       Impact factor: 1.827

Review 5.  Perioperative nutrition and metabolism in pediatric patients.

Authors:  K Imura; A Okada
Journal:  World J Surg       Date:  2000-12       Impact factor: 3.352

Review 6.  Neurodevelopmental implications of the general anesthesia in neonate and infants.

Authors:  Jin Hwan Lee; James Zhang; Ling Wei; Shan Ping Yu
Journal:  Exp Neurol       Date:  2015-04-08       Impact factor: 5.330

Review 7.  What is the role of enhanced recovery after surgery in children? A scoping review.

Authors:  Katherine L Pearson; Nigel J Hall
Journal:  Pediatr Surg Int       Date:  2016-09-27       Impact factor: 1.827

8.  Application of enhanced recovery after surgery during the perioperative period in infants with Hirschsprung's disease - A multi-center randomized clinical trial.

Authors:  Jie Tang; Xiang Liu; Tongshen Ma; Xiaofeng Lv; Weiwei Jiang; Jie Zhang; Changgui Lu; Huan Chen; Wei Li; Hongxing Li; Hua Xie; Chunxia Du; Qiming Geng; Jiexiong Feng; Weibing Tang
Journal:  Clin Nutr       Date:  2019-10-16       Impact factor: 7.324

9.  Assessing bias in studies of prognostic factors.

Authors:  Jill A Hayden; Danielle A van der Windt; Jennifer L Cartwright; Pierre Côté; Claire Bombardier
Journal:  Ann Intern Med       Date:  2013-02-19       Impact factor: 25.391

10.  The Reporting on ERAS Compliance, Outcomes, and Elements Research (RECOvER) Checklist: A Joint Statement by the ERAS® and ERAS® USA Societies.

Authors:  Kevin M Elias; Alexander B Stone; Katharine McGinigle; Jo'An I Tankou; Michael J Scott; William J Fawcett; Nicolas Demartines; Dileep N Lobo; Olle Ljungqvist; Richard D Urman
Journal:  World J Surg       Date:  2019-01       Impact factor: 3.352

View more
  2 in total

1.  The effect of an enhanced recovery protocol in pediatric patients who undergo colostomy closure and Malone procedures.

Authors:  Marina L Reppucci; Lea A Wehrli; Julie Schletker; Margo M Nolan; Jared Rieck; Souha Fares; Jill Ketzer; Kyle Rove; Alberto Pena; Luis de la Torre; Andrea Bischoff
Journal:  Pediatr Surg Int       Date:  2022-09-13       Impact factor: 2.003

2.  Pediatric robotic surgery: issues in management-expert consensus from the Italian Society of Pediatric and Neonatal Anesthesia and Intensive Care (SARNePI) and the Italian Society of Pediatric Surgery (SICP).

Authors:  Simonetta Tesoro; Piergiorgio Gamba; Mirko Bertozzi; Rachele Borgogni; Fabio Caramelli; Giovanni Cobellis; Giuseppe Cortese; Ciro Esposito; Tommaso Gargano; Rossella Garra; Giulia Mantovani; Laura Marchesini; Simonetta Mencherini; Mario Messina; Gerald Rogan Neba; Gloria Pelizzo; Simone Pizzi; Giovanna Riccipetitoni; Alessandro Simonini; Costanza Tognon; Mario Lima
Journal:  Surg Endosc       Date:  2022-09-19       Impact factor: 3.453

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.